Compile Data Set for Download or QSAR
maximum 50k data
Found 4281 with Last Name = 'marakovits' and Initial = 'j'
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101546(US8530494, 211 | US8530652, 125 | US8530652, 73)
Affinity DataKi:  1.60nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101542(US8530494, 207 | US8530652, 121 | US8530652, 69)
Affinity DataKi:  1.90nM EC50:  3nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101479(US8524710, 56 | US8530652, 50 | US8530652, 6)
Affinity DataKi:  2.80nM EC50:  0.940nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389112(CHEMBL2064556)
Affinity DataKi:  2.80nMAssay Description:Inhibition of PAK4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101537(US8530494, 204 | US8530652, 115 | US8530652, 64)
Affinity DataKi:  3nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50389111(CHEMBL2064555)
Affinity DataKi:  3.40nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM4838(US8524710, 83 | US8530494, 13 | US8530652, 52)
Affinity DataKi:  3.5nM EC50:  19nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM4838(US8524710, 83 | US8530494, 13 | US8530652, 52)
Affinity DataKi:  3.5nM EC50:  19nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101547(US8530494, 212 | US8530652, 126 | US8530652, 74)
Affinity DataKi:  3.60nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50122777(1-Phenyl-8,9-dihydro-7H-2,7,9a-triaza-benzo[cd]azu...)
Affinity DataKi:  4.10nMAssay Description:Inhibitory activity of the compound against human full length Poly (ADP-ribose) polymerase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50122775(1-(4-Hydroxymethyl-phenyl)-8,9-dihydro-7H-2,7,9a-t...)
Affinity DataKi:  4.20nMAssay Description:Inhibitory activity of the compound against human full length Poly (ADP-ribose) polymerase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50122781(1-Naphthalen-1-yl-8,9-dihydro-7H-2,7,9a-triaza-ben...)
Affinity DataKi:  4.90nMAssay Description:Inhibitory activity of the compound against human full length Poly (ADP-ribose) polymerase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101544(US8530494, 105 | US8530652, 123 | US8530652, 71)
Affinity DataKi:  5.20nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101548(US8530494, 108 | US8530652, 127 | US8530652, 75)
Affinity DataKi:  5.20nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50122779(1-(4-Chloro-phenyl)-8,9-dihydro-7H-2,7,9a-triaza-b...)
Affinity DataKi:  5.70nMAssay Description:Inhibitory activity of the compound against human full length Poly (ADP-ribose) polymerase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50122776(1-(4-Dimethylaminomethyl-phenyl)-8,9-dihydro-7H-2,...)
Affinity DataKi:  5.80nMAssay Description:Inhibitory activity of the compound against human full length Poly (ADP-ribose) polymerase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM34012(3-fluorophenylalanine derivative, 21b)
Affinity DataKi:  6nM ΔG°:  -45.4kJ/molepH: 7.5 T: 2°CAssay Description:The cis/trans conversion of cis-Suc-AEPFpNA peptide by the PPIase led to the cleavage of para nitroaniline by subtilisin which was monitored at 390 n...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389111(CHEMBL2064555)
Affinity DataKi:  6nMAssay Description:Inhibition of PAK4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50314714((R)-N-(1-(3-fluorophenyl)-3-hydroxypropan-2-yl)ben...)
Affinity DataKi:  6nMAssay Description:Displacement of WFYpSPFLE from human Pin1 catalytic domain after 10-20 mins by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50122772(1-(3-Dimethylaminomethyl-phenyl)-8,9-dihydro-7H-2,...)
Affinity DataKi:  6.30nMAssay Description:Inhibitory activity of the compound against human full length Poly (ADP-ribose) polymerase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101541(US8530494, 104 | US8530652, 120 | US8530652, 68)
Affinity DataKi:  6.70nM EC50:  20nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101504(US8524699, 91 | US8524710, 82 | US8530652, 31)
Affinity DataKi:  7.20nM EC50:  21nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50122774(1-(2-Chloro-phenyl)-8,9-dihydro-7H-2,7,9a-triaza-b...)
Affinity DataKi:  7.70nMAssay Description:Inhibitory activity of the compound against human full length Poly (ADP-ribose) polymerase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM34011(3-fluorophenylalanine derivative, 21a)
Affinity DataKi:  8nM ΔG°:  -44.7kJ/molepH: 7.5 T: 2°CAssay Description:The cis/trans conversion of cis-Suc-AEPFpNA peptide by the PPIase led to the cleavage of para nitroaniline by subtilisin which was monitored at 390 n...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101549(US8530494, 109 | US8530652, 128 | US8530652, 76)
Affinity DataKi:  8.30nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50122780(1-(3-Hydroxymethyl-phenyl)-8,9-dihydro-7H-2,7,9a-t...)
Affinity DataKi:  8.80nMAssay Description:Inhibitory activity of the compound against human full length Poly (ADP-ribose) polymerase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101543(US8530494, 206 | US8530652, 122 | US8530652, 70)
Affinity DataKi:  8.80nM EC50:  1.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101476(US8524710, 53 | US8530652, 3 | US8530652, 47)
Affinity DataKi:  11nM EC50:  16nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPoly [ADP-ribose] polymerase 1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50122773(1-(3-Trifluoromethyl-phenyl)-8,9-dihydro-7H-2,7,9a...)
Affinity DataKi:  11.2nMAssay Description:Inhibitory activity of the compound against human full length Poly (ADP-ribose) polymerase 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389116(CHEMBL2064561)
Affinity DataKi:  12nMAssay Description:Inhibition of PAK4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50056217(CHEMBL3353369)
Affinity DataKi:  12nMAssay Description:Inhibition of Pin1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389117(CHEMBL2064562)
Affinity DataKi:  13nMAssay Description:Inhibition of PAK4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101475(US8524710, 52 | US8530652, 2 | US8530652, 46)
Affinity DataKi:  14nM EC50:  36nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101530(US8530494, 29 | US8530494, 7 | US8530652, 57)
Affinity DataKi:  14nM EC50:  2.5nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101535(US8530494, 104 | US8530652, 113 | US8530652, 62)
Affinity DataKi:  15nM EC50:  15nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101515(US8524699, 26 | US8530652, 42 | US8530670, 31)
Affinity DataKi:  16nM EC50:  340nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101545(US8530494, 107 | US8530652, 124 | US8530652, 72)
Affinity DataKi:  16nM EC50:  4.40nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101513(US8524699, 18 | US8530652, 40 | US8530652, 85)
Affinity DataKi:  18nM EC50:  98nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101524(US8530652, 51 | US8530652, 96)
Affinity DataKi:  18nM EC50:  31nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101504(US8524699, 91 | US8524710, 82 | US8530652, 31)
Affinity DataKi:  20nM EC50:  103nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101536(CHEMBL3128043 | US8530494, 203 | US8530652, 114 | ...)
Affinity DataKi:  20nM EC50: <3.90nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101507(US8524710, 86 | US8530652, 34 | US8530652, 79)
Affinity DataKi:  21nM EC50:  778nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101534(US8530494, 202 | US8530652, 112 | US8530652, 61)
Affinity DataKi:  22nM EC50:  19nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101514(US8524699, 22 | US8530652, 41 | US8530652, 86)
Affinity DataKi:  24nM EC50:  147nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101518(US8524699, 46 | US8530652, 45 | US8530652, 90)
Affinity DataKi:  25nM EC50:  32nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389113(CHEMBL2064558)
Affinity DataKi:  30nMAssay Description:Inhibition of PAK4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGenome polyprotein(Human rhinovirus B)
Agouron Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50065621(CHEMBL94688 | [(S)-1-((S)-1-{(S)-3-Carbamoyl-1-[2-...)
Affinity DataKi:  30nMAssay Description:Catalytic rate constant (Kobs/[I]) of the compound was evaluated against human rhinovirus (HRV) serotype 14 3C Protease (3CP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM50389120(CHEMBL2064565)
Affinity DataKi:  31nMAssay Description:Inhibition of PAK4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM34013(3-methylphenylalanine derivative, 22a)
Affinity DataKi:  32nM ΔG°:  -41.3kJ/molepH: 7.5 T: 2°CAssay Description:The cis/trans conversion of cis-Suc-AEPFpNA peptide by the PPIase led to the cleavage of para nitroaniline by subtilisin which was monitored at 390 n...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Agouron Pharmaceuticals

US Patent
LigandPNGBDBM101639(US8530652, 84)
Affinity DataKi:  34nM EC50:  455nMAssay Description:The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 4281 total ) | Next | Last >>
Jump to: